Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.

B Hsu, MC Marin, AK El-Naggar, LC Stephens… - Oncogene, 1995 - europepmc.org
B Hsu, MC Marin, AK El-Naggar, LC Stephens, S Brisbay, TJ McDonnell
Oncogene, 1995europepmc.org
Deregulation of c-myc, frequently implicated in oncogenesis, is associated with increased
cell proliferation and also cell death. Similarly, the p53 tumor suppressor gene commonly
mutated in human tumors, is known to induce apoptosis or cell cycle arrest in its wild-type
conformation. Genetically altered mice simultaneously overexpressing c-myc and
possessing a disrupted p53 gene were used to investigate whether c-myc mediated
apoptosis requires wild-type p53. The accelerated development of malignant lymphomas in …
Deregulation of c-myc, frequently implicated in oncogenesis, is associated with increased cell proliferation and also cell death. Similarly, the p53 tumor suppressor gene commonly mutated in human tumors, is known to induce apoptosis or cell cycle arrest in its wild-type conformation. Genetically altered mice simultaneously overexpressing c-myc and possessing a disrupted p53 gene were used to investigate whether c-myc mediated apoptosis requires wild-type p53. The accelerated development of malignant lymphomas in these mice was found to be a consequence of enhanced proliferation and not reduced apoptosis resulting from the synergistic effect of c-myc overexpression and p53 inactivation.
europepmc.org